Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.82 - $1.36 $1.19 Million - $1.97 Million
-1,448,824 Reduced 95.07%
75,060 $69,000
Q3 2022

Nov 14, 2022

BUY
$0.91 - $2.27 $1.39 Million - $3.46 Million
1,523,884 New
1,523,884 $1.42 Million
Q2 2022

Aug 15, 2022

SELL
$1.5 - $2.57 $754,794 - $1.29 Million
-503,196 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.99 - $3.0 $1 Million - $1.51 Million
503,196 New
503,196 $1.17 Million
Q2 2021

Aug 13, 2021

SELL
$3.21 - $5.62 $1.52 Million - $2.66 Million
-472,531 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$2.16 - $4.26 $989,677 - $1.95 Million
458,184 Added 3193.59%
472,531 $1.56 Million
Q4 2020

Feb 16, 2021

BUY
$0.66 - $2.54 $9,469 - $36,441
14,347 New
14,347 $32,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $146M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.